The natural history of vascular disease in homocystinuria and the effects of treatment

Journal of Inherited Metabolic Disease

Volumn 20, Issue 2, 1997, Pages 295-300

  Wilcken, D E L ^a,c   Wilcken, B ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c PRINCE HENRY HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; CYSTATHIONINE BETA SYNTHASE; FOLIC ACID; HOMOCYSTEINE; HYDROXOCOBALAMIN; PYRIDOXINE; VITAMIN;

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; ENZYME DEFICIENCY; HEART INFARCTION; HOMOCYSTINURIA; HUMAN; LUNG EMBOLISM; SCHOOL CHILD; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; CHILD; CYSTATHIONINE BETA-SYNTHASE; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTINURIA; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 0030904875     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005373209964     Document Type: Conference Paper

References (15)

1. 6 safety issues. Ann NY Acad Sci 585: 321-330.
2. Celemajer DS, Sorensen K, Ryalls M, et al (1993) Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 22: 854-858.
3. Mandel H, Brenner B, Berant M, et al (1996) Coexistence of hereditary homocystinuria and factor V Leiden - effect on thrombosis. New Engl J Med 334: 763-768.
4. Mayer EL, Jacobsen DW, Robinson K (1996) Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27: 517-527.
5. Motulsky AG (1996) Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet 58: 17-20.
6. Mudd SH, Skovby F, Levy HL, et al (1985) The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37: 1-31.
7. Mudd SH, Levy HL, Skovby F (1995) Disorders of transsulfuration. In Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1279-1327.
8. Smolin LA, Benevenga J, Berlow S (1981) The use of betaine for the treatment of homocystinuria. J Pediatr 99: 467-472.
9. Stamler JS, Osborne JA, Jaraki O, et al (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 91: 308-318.
10. Tsai JC, Wang H, Perrella MA, et al (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97: 146-153.
11. Wilcken DEL, Dudman NPB (1992) Homocystinuria and atherosclerosis. In Lusis AJ, Rotter JI, Sparkes RS, eds. Molecular Genetics of Coronary Artery Disease. Candidate Genes and Processes in Atherosclerosis. Monogr Hum Genet, vol. 14. Basel: Karger, 311-324.
12. Wilcken B, Turner B (1973) Homocystinuria: reduced folate levels during pyridoxine treatment. Arch Dis Child 48: 58-62.
13. Wilcken DEL, Wilcken B (1976) The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest 57: 1079-1082.
14. Wilcken DEL, Wilcken B, Dudman NPB, Tyrrell PA (1983) Homocystinuria: the effects of betaine in the treatment of patients not responsive to pyridoxine. N Engl J Med 309: 448-453.
15. Wiley V, Dudman NPB, Wilcken DEL (1988) Interrelations between free and bound homocysteine and cysteine in homocystinuria. Metabolism 37: 191-195.